| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_21977e40c08969f3e950eb43ecafe0cb |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02P20-55 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C405-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C59-147
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-557 |
| filingDate |
2007-02-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_af600905d036cb5c031f8571decf2138
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2060c20445072eb3228d90a597d136cc |
| publicationDate |
2007-08-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2007185206-A1 |
| titleOfInvention |
Method for preparing 15-keto-prostaglandin E derivative |
| abstract |
Disclosed is an improved method for preparing 15-keto-prostaglandin E derivative. According to the invention, the deprotection of protected hydroxy group required in manufacturing a 15-keto-prostaglandin derivative is conducted under the presence of a phosphoric acid compound. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2013005995-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9242950-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-103180306-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-103764639-B
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-103764639-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-111351867-A |
| priorityDate |
2006-02-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |